Some other companies, including Opus Bio and Bluebird Bio, got rights to some products, in part because the companies had special expertise that the agencyâ€™s researchers desired. But Kite seems to have gotten the balance of them and N. C. I. technology accounts for the majority of its pipeline of possible products, though the company is diversifying. Dr. Rosenberg professes no interest in the business side of the Kite relationship. 